Decheng Capital LLC Top Holdings and 13F Report (2024)

→ Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad)

About Decheng Capital LLC

Investment Activity

Decheng Capital LLC has $745.65 million in total holdings as of March 31, 2024.
Decheng Capital LLC owns shares of 22 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
Approximately 45.34% of the portfolio was purchased this quarter.
About 15.64% of the portfolio was sold this quarter.
This quarter, Decheng Capital LLC has purchased 24 new stocks and bought additional shares in 2 stocks.
Decheng Capital LLC sold shares of 2 stocks and completely divested from 9 stocks this quarter.

Largest Holdings

Alpine Immune Sciences: $329,722,507
CG ONCOLOGY INC: $239,641,760
Zentalis Pharmaceuticals: $33,089,429
Illumina: $17,723,481
BeyondSpring: $17,700,571

Largest New Holdings this Quarter

CG ONCOLOGY INC: $239,641,760 Holding
4D Molecular Therapeutics: $11,082,023 Holding
MOONLAKE IMMUNOTHERAPEUTICS: $8,368,318 Holding
Crinetics Pharmaceuticals: $7,394,014 Holding
Cytokinetics: $6,593,355 Holding

Largest Purchases this Quarter

CG ONCOLOGY INC: 5,458,810 shares (about $239.64M)
Alpine Immune Sciences: 1,234,636 shares (about $48.94M)
4D Molecular Therapeutics: 347,835 shares (about $11.08M)
MOONLAKE IMMUNOTHERAPEUTICS: 166,600 shares (about $8.37M)
Crinetics Pharmaceuticals: 157,958 shares (about $7.39M)

Largest Sales this Quarter

10x Genomics: 163,719 shares (about $6.14M)
AtriCure: 19,462 shares (about $592.03K)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
ALPN Alpine Immune Sciences	$329,722,507	$48,940,971 ▲	17.4%	8,317,924	44.2%	Medical
CG ONCOLOGY INC	$239,641,760	$239,641,760 ▲	New Holding	5,458,810	32.1%	COM
ZNTL Zentalis Pharmaceuticals	$33,089,429		0.0%	2,099,583	4.4%	Medical
ILMN Illumina	$17,723,481	$6,619,923 ▲	59.6%	129,067	2.4%	Medical
BYSI BeyondSpring	$17,700,571		0.0%	4,958,143	2.4%	Medical
RCUS Arcus Biosciences	$16,421,635		0.0%	869,790	2.2%	Medical
KRYS Krystal Biotech	$11,702,812		0.0%	65,772	1.6%	Medical
FDMT 4D Molecular Therapeutics	$11,082,023	$11,082,023 ▲	New Holding	347,835	1.5%	Medical
EQ Equillium	$10,273,281		0.0%	4,447,308	1.4%	Medical
PHAT Phathom Pharmaceuticals	$9,027,000		0.0%	850,000	1.2%	Medical
MOONLAKE IMMUNOTHERAPEUTICS	$8,368,318	$8,368,318 ▲	New Holding	166,600	1.1%	COM
CRNX Crinetics Pharmaceuticals	$7,394,014	$7,394,014 ▲	New Holding	157,958	1.0%	Medical
TXG 10x Genomics	$7,349,687	$6,144,374 ▼	-45.5%	195,835	1.0%	Medical
CYTK Cytokinetics	$6,593,355	$6,593,355 ▲	New Holding	94,043	0.9%	Medical
LEGN Legend Biotech	$4,844,101	$4,844,101 ▲	New Holding	86,363	0.6%	Medical
MRUS Merus	$4,583,964	$4,583,964 ▲	New Holding	101,798	0.6%	Medical
AURA Aura Biosciences	$4,047,107		0.0%	515,555	0.5%	Medical
HLTH Cue Health	$1,697,076		0.0%	8,980,909	0.2%	Medical
PYXS Pyxis Oncology	$1,392,211		0.0%	326,810	0.2%	Medical
AADI Aadi Bioscience	$1,231,610		0.0%	526,329	0.2%	Medical
WGS GeneDx	$945,904		0.0%	103,604	0.1%	Medical
ATRC AtriCure	$815,165	$592,034 ▼	-42.1%	26,797	0.1%	Medical
PACB Pacific Biosciences of California	$0	$28,844,941 ▼	-100.0%	0	0.0%	Medical
IMGN ImmunoGen	$0	$19,566,865 ▼	-100.0%	0	0.0%	Medical
KRTX Karuna Therapeutics	$0	$14,875,970 ▼	-100.0%	0	0.0%	Medical
ROIV Roivant Sciences	$0	$14,371,031 ▼	-100.0%	0	0.0%	Medical
ARGX argenx	$0	$10,434,814 ▼	-100.0%	0	0.0%	Medical
SLRN Acelyrin	$0	$10,227,294 ▼	-100.0%	0	0.0%	Medical
LNTH Lantheus	$0	$5,716,152 ▼	-100.0%	0	0.0%	Medical
TERN Terns Pharmaceuticals	$0	$4,635,710 ▼	-100.0%	0	0.0%	Medical
SCYX SCYNEXIS	$0	$1,238,888 ▼	-100.0%	0	0.0%	Medical